Eton Pharmaceuticals Inc (ETON)
7.00
+0.09
(+1.30%)
USD |
NASDAQ |
Oct 04, 16:00
6.97
-0.03
(-0.43%)
After-Hours: 20:00
Eton Pharmaceuticals Shareholders Equity (Annual): 15.48M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.48M |
| December 31, 2022 | 13.08M |
| December 31, 2021 | 17.63M |
| December 31, 2020 | 15.66M |
| Date | Value |
|---|---|
| December 31, 2019 | 10.55M |
| December 31, 2018 | 26.30M |
| December 31, 2017 | 12.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
10.55M
Minimum
2019
17.63M
Maximum
2021
14.48M
Average
15.48M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 4.952B |
| Integra Lifesciences Holdings Corp | 1.588B |
| Elutia Inc | -38.60M |
| Immuneering Corp | 90.58M |
| Journey Medical Corp | 20.35M |